{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:25:02Z","timestamp":1770348302729,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13046-018-0847-7","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T12:54:16Z","timestamp":1533646456000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11\/STAT3 signaling pathway"],"prefix":"10.1186","volume":"37","author":[{"given":"Liang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingxiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxiong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiling","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,7]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","volume":"4","author":"S Misra","year":"2003","unstructured":"Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167\u201376.","journal-title":"Lancet Oncol"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108.","journal-title":"CA Cancer J Clin"},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1411372","volume":"373","author":"TH Baron","year":"2015","unstructured":"Baron TH, Grimm IS, Swanstrom LL. Interventional approaches to gallbladder disease. N Engl J Med. 2015;373:357\u201365.","journal-title":"N Engl J Med"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jamcollsurg.2010.09.009","volume":"212","author":"JM Butte","year":"2011","unstructured":"Butte JM, Matsuo K, Gonen M, D'Angelica MI, Waugh E, Allen PJ, Fong Y, DeMatteo RP, Blumgart L, Endo I, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50\u201361.","journal-title":"J Am Coll Surg"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1470-2045(11)70301-1","volume":"13","author":"J Lee","year":"2012","unstructured":"Lee J, Park SH, Chang HM, Kim JS, Choi HJ, Lee MA, Jang JS, Jeung HC, Kang JH, Lee HW, et al. Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2012;13:181\u20138.","journal-title":"Lancet Oncol"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1245\/s10434-013-3292-z","volume":"21","author":"XS Wu","year":"2014","unstructured":"Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, Bao RF, Shu YJ, Ding QC, et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014;21:449\u201357.","journal-title":"Ann Surg Oncol"},{"key":"847_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30324-8","volume":"18","author":"K Hemminki","year":"2017","unstructured":"Hemminki K, Hemminki A, Forsti A, Sundquist K, Li X. Genetics of gallbladder cancer. Lancet Oncol. 2017;18:e296.","journal-title":"Lancet Oncol"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccell.2015.09.006","volume":"28","author":"X Yan","year":"2015","unstructured":"Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao SD, Zhang Y, Yang L, Shan W, He Q, et al. Comprehensive genomic characterization of long non-coding RNAs across human cancers. Cancer Cell. 2015;28:529\u201340.","journal-title":"Cancer Cell"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","volume":"152","author":"PJ Batista","year":"2013","unstructured":"Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152:1298\u2013307.","journal-title":"Cell"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cell.2009.02.006","volume":"136","author":"CP Ponting","year":"2009","unstructured":"Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629\u201341.","journal-title":"Cell"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in Cancer pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nature17161","volume":"531","author":"E Leucci","year":"2016","unstructured":"Leucci E, Vendramin R, Spinazzi M, Laurette P, Fiers M, Wouters J, Radaelli E, Eyckerman S, Leonelli C, Vanderheyden K, et al. Melanoma addiction to the long non-coding RNA SAMMSON. Nature. 2016;531:518\u201322.","journal-title":"Nature"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ncb3538","volume":"19","author":"JH Yuan","year":"2017","unstructured":"Yuan JH, Liu XN, Wang TT, Pan W, Tao QF, Zhou WP, Wang F, Sun SH. The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1. Nat Cell Biol. 2017;19:820\u201332.","journal-title":"Nat Cell Biol"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/hep.26361","volume":"58","author":"D Xu","year":"2013","unstructured":"Xu D, Yang F, Yuan JH, Zhang L, Bi HS, Zhou CC, Liu F, Wang F, Sun SH. Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt\/beta-catenin signaling. Hepatology. 2013;58:739\u201351.","journal-title":"Hepatology"},{"key":"847_CR15","doi-asserted-by":"crossref","first-page":"e6536","DOI":"10.1590\/1414-431x20176536","volume":"51","author":"C Zhang","year":"2017","unstructured":"Zhang C, Yuan J, Hu H, Chen W, Liu M, Zhang J, Sun S, Guo Z. Long non-coding RNA CHCHD4P4 promotes epithelial-mesenchymal transition and inhibits cell proliferation in calcium oxalate-induced kidney damage. Braz J Med Biol Res. 2017;51:e6536.","journal-title":"Braz J Med Biol Res"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/ncb3473","volume":"19","author":"A Lin","year":"2017","unstructured":"Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C, Li J, Ye Y, Yao J, Liang K, et al. The LINK-A lncRNA interacts with PtdIns (3,4,5) P3 to hyperactivate AKT and confer resistance to AKT inhibitors. Nat Cell Biol. 2017;19:238\u201351.","journal-title":"Nat Cell Biol"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ncb3595","volume":"19","author":"S Grelet","year":"2017","unstructured":"Grelet S, Link LA, Howley B, Obellianne C, Palanisamy V, Gangaraju VK, Diehl JA, Howe PH. A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression. Nat Cell Biol. 2017;19:1105\u201315.","journal-title":"Nat Cell Biol"},{"key":"847_CR18","first-page":"32","volume":"3","author":"EM Reis","year":"2012","unstructured":"Reis EM, Verjovski-Almeida S. Perspectives of long non-coding RNAs in Cancer diagnostics. Front Genet. 2012;3:32.","journal-title":"Front Genet"},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/carcin\/bgs381","volume":"34","author":"L Zhang","year":"2013","unstructured":"Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F, Sun SH. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 2013;34:577\u201386.","journal-title":"Carcinogenesis"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.1111\/febs.13839","volume":"283","author":"XT Zhu","year":"2016","unstructured":"Zhu XT, Yuan JH, Zhu TT, Li YY, Cheng XY. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 2016;283:3739\u201354.","journal-title":"FEBS J"},{"key":"847_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13046-015-0136-7","volume":"34","author":"L Deng","year":"2015","unstructured":"Deng L, Yang SB, Xu FF, Zhang JH. Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015;34:18.","journal-title":"J Exp Clin Cancer Res"},{"key":"847_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb3295","volume":"18","author":"A Lin","year":"2016","unstructured":"Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, et al. The LINK-A lncRNA activates normoxic HIF1alpha signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213\u201324.","journal-title":"Nat Cell Biol"},{"key":"847_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12943-017-0681-0","volume":"16","author":"JK Li","year":"2017","unstructured":"Li JK, Chen C, Liu JY, Shi JZ, Liu SP, Liu B, Wu DS, Fang ZY, Bao Y, Jiang MM, et al. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling. Mol Cancer. 2017;16:111.","journal-title":"Mol Cancer"},{"key":"847_CR24","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embr.201744147","volume":"18","author":"XS Wu","year":"2017","unstructured":"Wu XS, Wang F, Li HF, Hu YP, Jiang L, Zhang F, Li ML, Wang XA, Jin YP, Zhang YJ, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 2017;18:1837\u201353.","journal-title":"EMBO Rep"},{"key":"847_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.541","volume":"6","author":"MZ Ma","year":"2015","unstructured":"Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, Quan ZW. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015;6:e1583.","journal-title":"Cell Death Dis"},{"key":"847_CR26","doi-asserted-by":"crossref","first-page":"33137","DOI":"10.18632\/oncotarget.16561","volume":"8","author":"P Zhang","year":"2017","unstructured":"Zhang P, Cao P, Zhu X, Pan M, Zhong K, He R, Li Y, Jiao X, Gao Y. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma. Oncotarget. 2017;8:33137\u201343.","journal-title":"Oncotarget"},{"key":"847_CR27","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1158\/0008-5472.CAN-15-3047","volume":"76","author":"MZ Ma","year":"2016","unstructured":"Ma MZ, Zhang Y, Weng MZ, Wang SH, Hu Y, Hou ZY, Qin YY, Gong W, Zhang YJ, Kong X, et al. Long noncoding RNA GCASPC, a target of miR-17-3p, negatively regulates pyruvate carboxylase-dependent cell proliferation in gallbladder Cancer. Cancer Res. 2016;76:5361\u201371.","journal-title":"Cancer Res"},{"key":"847_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-016-0436-6","volume":"35","author":"SH Wang","year":"2016","unstructured":"Wang SH, Ma F, Tang ZH, Wu XC, Cai Q, Zhang MD, Weng MZ, Zhou D, Wang JD, Quan ZW. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. J Exp Clin Cancer Res. 2016;35:160.","journal-title":"J Exp Clin Cancer Res"},{"key":"847_CR29","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.18632\/oncotarget.13621","volume":"8","author":"L Yang","year":"2017","unstructured":"Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget. 2017;8:3104\u201310.","journal-title":"Oncotarget"},{"key":"847_CR30","first-page":"775","volume":"27","author":"JH Wang","year":"2012","unstructured":"Wang JH, Li LF, Yu Y, Li B, Jin HJ, Shen DH, Li J, Jiang XQ, Qian QJ. Establishment and characterization of a cell line, EH-GB2, derived from hepatic metastasis of gallbladder cancer. Oncol Rep. 2012;27:775\u201382.","journal-title":"Oncol Rep"},{"key":"847_CR31","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jhep.2016.01.019","volume":"64","author":"X Wang","year":"2016","unstructured":"Wang X, Sun W, Shen W, Xia M, Chen C, Xiang D, Ning B, Cui X, Li H, Li X, et al. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6\/STAT3 axis. J Hepatol. 2016;64:1283\u201394.","journal-title":"J Hepatol"},{"key":"847_CR32","first-page":"51","volume":"31","author":"LX Fu","year":"2017","unstructured":"Fu LX, Lian QW, Pan JD, Xu ZL, Zhou TM, Ye B. JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2\/STAT3 signaling. J Biol Regul Homeost Agents. 2017;31:51\u20138.","journal-title":"J Biol Regul Homeost Agents"},{"key":"847_CR33","doi-asserted-by":"publisher","first-page":"19467","DOI":"10.18632\/oncotarget.14444","volume":"8","author":"L Enyu","year":"2017","unstructured":"Enyu L, Na W, Chuanzong Z, Ben W, Xiaojuan W, Yan W, Zequn L, Jianguo H, Jiayong W, Benjia L, et al. The clinical significance and underlying correlation of pStat-3 and integrin alphavbeta6 expression in gallbladder cancer. Oncotarget. 2017;8:19467\u201377.","journal-title":"Oncotarget"},{"key":"847_CR34","doi-asserted-by":"publisher","first-page":"D91","DOI":"10.1093\/nar\/gkh012","volume":"32","author":"A Sandelin","year":"2004","unstructured":"Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32:D91\u20134.","journal-title":"Nucleic Acids Res"},{"key":"847_CR35","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/hep.29405","volume":"67","author":"J Zhang","year":"2018","unstructured":"Zhang J, Li Z, Liu L, Wang Q, Li S, Chen D, Hu Z, Yu T, Ding J, Li J, et al. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6\/STAT3 signaling pathway. Hepatology. 2018;67:171\u201387.","journal-title":"Hepatology"},{"key":"847_CR36","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47:199\u2013208.","journal-title":"Nat Genet"},{"key":"847_CR37","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1002\/jcb.26451","volume":"119","author":"KK Sun","year":"2018","unstructured":"Sun KK, Hu PP, Xu F. Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis. J Cell Biochem. 2018;119:3099\u2013110.","journal-title":"J Cell Biochem"},{"key":"847_CR38","doi-asserted-by":"crossref","first-page":"47957","DOI":"10.18632\/oncotarget.18204","volume":"8","author":"Q Cai","year":"2017","unstructured":"Cai Q, Jin L, Wang S, Zhou D, Wang J, Tang Z, Quan Z. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Oncotarget. 2017;8:47957\u201368.","journal-title":"Oncotarget"},{"key":"847_CR39","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.biopha.2016.10.064","volume":"84","author":"F Ma","year":"2016","unstructured":"Ma F, Wang SH, Cai Q, Zhang MD, Yang Y, Ding J. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer. Biomed Pharmacother. 2016;84:1249\u201355.","journal-title":"Biomed Pharmacother"},{"key":"847_CR40","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.3892\/mmr.2016.4913","volume":"13","author":"PL Wang","year":"2016","unstructured":"Wang PL, Liu B, Xia Y, Pan CF, Ma T, Chen YJ. Long non-coding RNA-low expression in tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression. Mol Med Rep. 2016;13:3074\u201382.","journal-title":"Mol Med Rep"},{"key":"847_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/cbdd.12967","volume":"90","author":"XC Wu","year":"2017","unstructured":"Wu XC, Wang SH, Ou HH, Zhu B, Zhu Y, Zhang Q, Yang Y, Li H. The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition. Chem Biol Drug Des. 2017;90:456\u201363.","journal-title":"Chem Biol Drug Des"},{"key":"847_CR42","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1476-4598-13-156","volume":"13","author":"MZ Ma","year":"2014","unstructured":"Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY, Gong W, Quan ZW. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer. 2014;13:156.","journal-title":"Mol Cancer"},{"key":"847_CR43","doi-asserted-by":"publisher","first-page":"12867","DOI":"10.1007\/s13277-016-5210-z","volume":"37","author":"SH Wang","year":"2016","unstructured":"Wang SH, Zhang MD, Wu XC, Weng MZ, Zhou D, Quan ZW. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion. Tumour Biol. 2016;37:12867\u201375.","journal-title":"Tumour Biol"},{"key":"847_CR44","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccr.2013.08.023","volume":"24","author":"M Steder","year":"2013","unstructured":"Steder M, Alla V, Meier C, Spitschak A, Pahnke J, Furst K, Kowtharapu BS, Engelmann D, Petigk J, Egberts F, et al. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT\/STAT3 signaling. Cancer Cell. 2013;24:512\u201327.","journal-title":"Cancer Cell"},{"key":"847_CR45","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2016.03.014","volume":"29","author":"R Kesselring","year":"2016","unstructured":"Kesselring R, Glaesner J, Hiergeist A, Naschberger E, Neumann H, Brunner SM, Wege AK, Seebauer C, Kohl G, Merkl S, et al. IRAK-M expression in tumor cells supports colorectal Cancer progression through reduction of antimicrobial defense and stabilization of STAT3. Cancer Cell. 2016;29:684\u201396.","journal-title":"Cancer Cell"},{"key":"847_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1756-9966-30-56","volume":"30","author":"D David","year":"2011","unstructured":"David D, Rajappan LM, Balachandran K, Thulaseedharan JV, Nair AS, Pillai RM. Prognostic significance of STAT3 and phosphorylated STAT3 in human soft tissue tumors - a clinicopathological analysis. J Exp Clin Cancer Res. 2011;30:56.","journal-title":"J Exp Clin Cancer Res"},{"key":"847_CR47","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13046-017-0632-z","volume":"36","author":"M Granato","year":"2017","unstructured":"Granato M, Gilardini Montani MS, Santarelli R, D'Orazi G, Faggioni A, Cirone M. Apigenin, by activating p53 and inhibiting STAT3, modulates the balance between pro-apoptotic and pro-survival pathways to induce PEL cell death. J Exp Clin Cancer Res. 2017;36:167.","journal-title":"J Exp Clin Cancer Res"},{"key":"847_CR48","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2013.06.017","volume":"24","author":"TL Putoczki","year":"2013","unstructured":"Putoczki TL, Thiem S, Loving A, Busuttil RA, Wilson NJ, Ziegler PK, Nguyen PM, Preaudet A, Farid R, Edwards KM, et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell. 2013;24:257\u201371.","journal-title":"Cancer Cell"},{"key":"847_CR49","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccr.2014.03.010","volume":"25","author":"JH Yuan","year":"2014","unstructured":"Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ, Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25:666\u201381.","journal-title":"Cancer Cell"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-018-0847-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-018-0847-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T11:12:31Z","timestamp":1604747551000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-018-0847-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1186\/s13046-018-0847-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,7]]},"assertion":[{"value":"26 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Use of patient tissue samples and nude mice were approved by the Review Board of Eastern Hepatobiliary Surgery Hospital (Shanghai, China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors agree for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"186"}}